General MedicationsOPHTHALMICStandard
VISIONBLUE
TRYPAN BLUE
Standard Dose
0.06%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VISIONBLUE is listed in Drugs@FDA under application 021670 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TRYPAN BLUE Form and strength SOLUTION;OPHTHALMIC - 0.06% Sponsor DORC Submission history Latest submission status date: 2023-12-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview VISIONBLUE is listed in Drugs@FDA under application 021670 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRYPAN BLUE Form and strength SOLUTION;OPHTHALMIC - 0.06% Sponsor DORC Submission history Latest submission status date: 2023-12-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.